Literature DB >> 6765952

Changes in thyroid functions in patients with euthyroid Graves' disease.

H Tamai, T Nakagawa, N Ohsako, O Fukino, H Takahashi, F Matsuzuka, K Kuma, S Nagataki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6765952     DOI： 10.1210/jcem-50-1-108

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Concomitant euthyroid Graves' ophthalmopathy and isolated ocular myasthenia gravis.

Authors:  H Raef; M Ladinsky; R Arem
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

Review 2.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

3.  Long-term follow-up of ophthalmic Graves' disease.

Authors:  P J Agapitos; I R Hart
Journal:  CMAJ       Date:  1987-02-15       Impact factor: 8.262

4.  Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.

Authors:  W M Wiersinga; T Smit; R van der Gaag; L Koornneef
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

5.  Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.

Authors:  K Kasagi; R Takeuchi; T Misaki; T Kousaka; S Miyamoto; Y Iida; J Konishi
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

6.  Systemic lupus erythematosus and thyrotoxicosis: a hitherto little recognised association.

Authors:  S Rodrigué; H Laborde; P M Catoggio
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

7.  Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.

Authors:  K Ikekubo; M Hino; H Ito; T Koh; T Ishihara; H Kurahachi; K Kasagi; A Hidaka; T Mori
Journal:  Ann Nucl Med       Date:  1990-07       Impact factor: 2.668

Review 8.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

9.  Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test.

Authors:  P G Walfish; I S Gottesman; J L Baxter
Journal:  Can Med Assoc J       Date:  1982-08-15       Impact factor: 8.262

10.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.